Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/ valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: Results fromPARADIGM-HF

Michael Böhm, Robin Young, Pardeep S. Jhund, Scott D. Solomon, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor C. Shi, Karl Swedberg, Michael R. Zile, Milton Packer, John J.V. McMurray

Research output: Contribution to journalArticlepeer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/ valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: Results fromPARADIGM-HF'. Together they form a unique fingerprint.

Medicine & Life Sciences